The NK-92 cell line-30 years later: its impact on natural killer cell research and treatment of cancer Jul 19, 2023 | Uncategorized
Inferred immune-cell activity is an independent predictor of HER2 negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial Jul 7, 2023 | Breast Cancer
Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies Jul 7, 2023 | Cancer